Concepedia
Statistics
Publications
8
Citations
691
H-Index
Active since
2003
Affiliations
ToolGen (South Korea)(Current)
University of California, Los Angeles
John F. Kennedy Medical Center
ArmaGen (United States)
Henry Ford Hospital
Oscar R. Diago is an author at ToolGen (South Korea) specializing in oncology, medicine, and pharmacology.
Publications per year
2003–2020
Phase 1 trial of vocimagene amiretrorepvec and 5-fluorocytosine for recurrent high-grade glioma
Timothy F. Cloughesy, Joseph Landolfi, Daniel J. Hogan et al. · Science Translational Medicine · 2016 · 199 citations · Full text
Medicine, Oncology, Pharmacology +16
Durable complete responses in some recurrent high-grade glioma patients treated with Toca 511 + Toca FC
Timothy F. Cloughesy, Joseph Landolfi, Michael A. Vogelbaum et al. · Neuro-Oncology · 2018 · 176 citations · Full text
Design and Selection of Toca 511 for Clinical Use: Modified Retroviral Replicating Vector With Improved Stability and Gene Expression
Omar D. Perez, Christopher R. Logg, Kei Hiraoka et al. · Molecular Therapy · 2012 · 138 citations · Full text
Medicine, Oncology, Pharmacology +13
Intravenous Administration of Retroviral Replicating Vector, Toca 511, Demonstrates Therapeutic Efficacy in Orthotopic Immune-Competent Mouse Glioma Model
Tiffany Huang, Shraddha Parab, Ryan Burnett et al. · Human Gene Therapy · 2014 · 64 citations · Full text
Retroviral Replicating Vectors Deliver Cytosine Deaminase Leading to Targeted 5-Fluorouracil-Mediated Cytotoxicity in Multiple Human Cancer Types
Chris Twitty, Oscar R. Diago, Daniel J. Hogan et al. · Human Gene Therapy Methods · 2015 · 37 citations
Medicine, Oncology, Pharmacology +14
1–5 of 8